-+ 0.00%
-+ 0.00%
-+ 0.00%

HeartSciences partners with Bunkerhill Health to offer FDA-cleared ECG-EF algorithm on MyoVista Insights platform

PUBT·06/02/2026 12:33:45
Listen to the news
HeartSciences partners with Bunkerhill Health to offer FDA-cleared ECG-EF algorithm on MyoVista Insights platform
  • HeartSciences launched MyoVista Insights version 1.3, adding an AI-ECG Algorithm Marketplace that integrates third-party models into its platform.
  • Bunkerhill Health’s FDA-cleared ECG-EF algorithm is the first available, aimed at detecting reduced LVEF of 40% or less from 12-lead ECGs.
  • Move positions MyoVista Insights as a distribution channel for AI-ECG developers using a recurring SaaS revenue model.
  • HeartSciences cited Medicare reimbursement under APC 5734 at about USD 136 per assessment for 2026 as a key adoption driver.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Heartsciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202606020830PRIMZONEFULLFEED9730042) on June 02, 2026, and is solely responsible for the information contained therein.